Ge et al. concluded that BRIX1 mRNA levels are higher in colorectal cancer (CRC) tissues than in normal tissues, and that the expression of BRIX1 correlates with CRC tumorstage, which is a risk factor for overall survival in patients with CRC [56]. This evidence concerns the gene BRIX1 and colorectal carcinoma.